A melanoma cell can dodge a targeted drug in dozens of different ways, each driven by a different genetic mutation. But what ...

Your pathology report includes vital information about your brain tumor that can guide treatment. Get to know how to interpret common terms.

Preliminary thyroid cancer treatment research identifies a shared molecular axis in radioiodine-refractory and anaplastic thyroid carcinomas. Learn how ...

According to the study, the grave predates the Black Death burial pits from medieval Europe by approximately 800 years.

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent. By Gina Kolata The Food and Drug ...

New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda (tovorafenib) represents ...

Two BRAF-targeted agents already used together in several solid tumors have won parallel regulatory support in Europe. In its March 2026 meeting, the European Medicines Agency’s Committee for ...

Traditional FDA approval covers encorafenib plus cetuximab with fluorouracil-based chemotherapy for adult metastatic CRC with BRAF V600E mutations confirmed by an FDA-authorized test. BREAKWATER ...

Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, with important implications for diagnosis and treatment, according to ...

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the Medical Oncology Department of the Catalan Institute of Oncology (ICO) in ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...